Internal Medicine, Hematology & Oncology · Miami, FL
NPI
1831186162
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8900 N Kendall Dr, Miami Cancer Institute
Miami, FL, 33176
Phone (786) 596-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,133 services
Medicare patients, 2024
417
Average age 75
Drug cost, 2024
$2.9M
1,199 prescriptions
Company payments, 2025
$950
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frances A Behrmann was code 99214 (office e&m - established), 286 times for 141 patients. In total Frances A Behrmann billed 1,133 services in 19 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 286 | 141 | $72.81 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 283 | 139 | $13.49 | $3,817 |
| 99214 Office E&M - Established | Office | 106 | 92 | $102.50 | $11K |
| 99215 Office E&M - Established | Facility | 102 | 52 | $113.31 | $12K |
| 99213 Office E&M - Established | Office | 96 | 88 | $68.78 | $6,602 |
| 85025 Blood Count | Office | 54 | 50 | $7.61 | $411 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 29 | $13.68 | $602 |
| 99215 Office E&M - Established | Office | 37 | 33 | $142.96 | $5,290 |
| 99204 Office E&M - New | Office | 30 | 30 | $119.00 | $3,570 |
| 99205 Office E&M - New | Facility | 16 | 16 | $154.41 | $2,471 |
By year: 2022 $63K for 632 services; 2023 $76K for 841 services; 2024 $72K for 1,133 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 54 | 50 | $7.61 | $411 |
Medicare prescription drug claims, 2024
In 2024, the drug Frances A Behrmann prescribed most often to Medicare patients was Anastrozole, with 570 prescriptions and refills. In total Frances A Behrmann wrote 1,199 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 570 | 1,451 | 205 | $7,838 |
| Letrozole Generic | 171 | 426 | 59 | $3,521 |
| Ibrance Palbociclib | 135 | 135 | 17 | $2.1M |
| Eliquis Apixaban | 85 | 89 | 20 | $48K |
| Exemestane Generic | 72 | 197 | 36 | $15K |
| Verzenio Abemaciclib | 27 | 27 | Under 11 | $413K |
| Ondansetron Hcl Generic | 19 | 19 | 16 | $63.17 |
| Ondansetron Odt Ondansetron | 12 | 12 | Under 11 | $62.45 |
| Gabapentin Generic | 12 | 16 | Under 11 | $296 |
| Hydroxyurea Generic | 11 | 31 | Under 11 | $220 |
Brand drugs: 288 claims; generic drugs: 911 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frances A Behrmann $950 ($950 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $289.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $289 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $153 |
| Merck Sharp & Dohme LLC MRK | 6 | $145 |
| Lilly USA, LLC LLY | 10 | $109 |
| Daiichi Sankyo Inc. 4568.T | 3 | $78.81 |
| Pfizer Inc. PFE | 3 | $64.31 |
| Tempus AI, Inc TEM | 2 | $48.1 |
| Incyte Corporation INCY | 2 | $38.51 |
| Pharmacosmos Therapeutics Inc. | 1 | $24.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.